Exagen
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Exagen and other ETFs, options, and stocks.About XGN
Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand.
CEOJohn Aballi
CEOJohn Aballi
Employees209
Employees209
HeadquartersVista, California
HeadquartersVista, California
Founded2002
Founded2002
Employees209
Employees209
XGN Key Statistics
Market cap102.44M
Market cap102.44M
Price-Earnings ratio-5.07
Price-Earnings ratio-5.07
Dividend yield—
Dividend yield—
Average volume719.73K
Average volume719.73K
High today$4.67
High today$4.67
Low today$4.51
Low today$4.51
Open price$4.63
Open price$4.63
Volume20.43K
Volume20.43K
52 Week high$12.23
52 Week high$12.23
52 Week low$2.67
52 Week low$2.67
Stock Snapshot
With a market cap of 102.44M, Exagen(XGN) trades at $4.52. The stock has a price-to-earnings ratio of -5.07.
On 2026-01-20, Exagen(XGN) stock moved within a range of $4.51 to $4.67. With shares now at $4.52, the stock is trading +0.2% above its intraday low and -3.2% below the session's peak.
Trading activity shows a volume of 20.43K, compared to an average daily volume of 719.73K.
The stock's 52-week range extends from a low of $2.67 to a high of $12.23.
The stock's 52-week range extends from a low of $2.67 to a high of $12.23.
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own XGN. This list is generated using Robinhood data, and it’s not a recommendation.